Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7

被引：1
|
作者：
Chen, Zhi-Ting [1 ,2 ]
Zhao, Zhen-Hua [2 ,3 ]
Chen, Li-Na [1 ,2 ]
Fan, Fei [4 ]
Cai, Guo-En [1 ,2 ]
Weng, Hui-Dan [1 ,2 ]
Wang, Ying-Qing [1 ,2 ]
Liao, Lian-Ming [5 ]
Chen, Xiao-Chun [2 ]
Huang, En [6 ]
Ye, Qin-Yong [1 ,2 ]
机构：
[1] Fujian Med Univ, Fujian Inst Geriatr, Dept Neurol, Union Hosp, Fuzhou 350001, Peoples R China
[2] Fujian Med Univ, Inst Neurosci, Fujian Key Lab Mol Neurol, Fuzhou 350001, Peoples R China
[3] Fujian Med Univ, Shengli Clin Med Coll, Fuzhou 350001, Peoples R China
[4] Fujian Hlth Coll, Fuzhou 350101, Peoples R China
[5] Fujian Med Univ, Ctr Translat Med Hematol, Union Hosp, Fuzhou 350001, Peoples R China
[6] Fujian Med Univ, Sch Basic Med Sci, Fuzhou 350122, Peoples R China
来源：
STEM CELL RESEARCH | 2021年 / 51卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.scr.2021.102175
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
PARK7 mutations are accountable for the inherited Parkinson's disease. An induced pluripotent stem cell (iPSC) line FJMUUHi001-A was generated by expressing five reprogramming factors, OCT3/4, SOX2, c-MYC, KLF4 and BCL-XL, in peripheral blood mononuclear cells from a 32-year old patient carrying a homozygous mutation of c.189dupA in PARK7. The iPSCs with a normal karyotype had the abilities to differentiate into three germ layers and expressed pluripotency markers without detectable residual plasmids. The cell line FJMUUHi001-A carrying the truncating protein PARK7 could be a useful tool to help comprehend the function of PARK7 in the iPSCs and differentiated cells from them.
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Generation of an induced pluripotent stem cell line MNDINSi001-A from a patient with neonatal diabetes caused by a heterozygous INS mutation
    Panova, Alexandra, V
    Klementieva, Natalia, V
    Sycheva, Anna, V
    Goliusova, Daria, V
    Khokhlov, Nikolay, V
    Zubkova, Natalia A.
    Tiulpakov, Anatoly N.
    Kiselev, Sergey L.
    STEM CELL RESEARCH, 2020, 47
  • [22] Generation of induced pluripotent stem cell line (XDCMHi001-A) from an Ankylosing spondylitis patient with JAK2 mutation
    Hu, Jintao
    Ren, Weifan
    Qiu, Weiguo
    Lv, Jianlan
    Zhang, Cui
    Xu, Chao
    Du, Weibin
    Wu, Mengrui
    Wang, Jinfu
    Quan, Renfu
    STEM CELL RESEARCH, 2020, 45
  • [23] Generation of induced pluripotent stem cell line RCPCMi004-A derived from patient with Parkinson's disease with deletion of the exon 2 in PARK2 gene
    Shuvalova, L. D.
    Eremeev, A. V.
    Bogomazova, A. N.
    Novosadova, E. V.
    Zerkalenkova, E. A.
    Olshanskaya, Yu. V.
    Fedotova, E. Y.
    Glagoleva, E. S.
    Illarioshkin, S. N.
    Lebedeva, O. S.
    Lagarkova, M. A.
    STEM CELL RESEARCH, 2020, 44
  • [24] Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene
    Gustavsson, Nadja
    Marote, Ana
    Pomeshchik, Yuriy
    Russ, Kaspar
    Azevedo, Carla
    Chumarina, Margarita
    Goldwurm, Stefano
    Collin, Anna
    Pinto, Luisa
    Salgado, Antonio J.
    Klementieva, Oxana
    Roybon, Laurent
    Savchenko, Ekaterina
    STEM CELL RESEARCH, 2019, 34
  • [25] Generation of an induced pluripotent stem cell line (DANi-011A) from a Parkinson's disease patient with a LRRK2 p.G2019S mutation
    Chen, Muwan
    Maimaitili, Muyesier
    Buchholdta, Susanne Hvolbol
    Jensen, Uffe Birk
    Febbraro, Fabia
    Denham, Mark
    STEM CELL RESEARCH, 2020, 45
  • [26] Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease
    Marote, Ana
    Pomeshchik, Yuriy
    Goldwurm, Stefano
    Collin, Anna
    Lamas, Nuno J.
    Pinto, Luisa
    Salgado, Antonio J.
    Roybon, Laurent
    STEM CELL RESEARCH, 2018, 27 : 82 - 85
  • [27] Generation of induced pluripotent stem cell line LNDWCHi001-A from a patient with early-onset Parkinson's disease carrying the homozygous c.1898C > T (p. A633V) mutation in the PLA2G6 gene
    Huang, Jingxuan
    Jiang, Qirui
    Pang, Dejiang
    Yu, Yujiao
    Cui, Yiyuan
    Li, Chunyu
    Shang, Huifang
    STEM CELL RESEARCH, 2024, 75
  • [28] Generation of an induced pluripotent stem cell (iPSC) line (EXSURGi001-A) from a patient homozygous for the p.Ala165Thr mutation in the MTARC1 gene
    Tang, Peter
    Keshi, Eriselda
    Wilken, Silvana
    Wutsdorff, Louise
    Mougnekabol, Julienne
    Pratschke, Johann
    Sauer, Igor M.
    Haep, Nils
    STEM CELL RESEARCH, 2024, 80
  • [29] Generation of induced pluripotent stem cell line, ICGi034-A, by reprogramming peripheral blood mononuclear cells from a patient with Parkinson's disease associated with GBA mutation
    Grigor'eva, Elena, V
    Drozdova, Elena S.
    Sorogina, Diana A.
    Malakhova, Anastasia A.
    Pavlova, Sofia, V
    Vyatkin, Yuri V.
    Khabarova, Elena A.
    Rzaev, Jamil A.
    Medvedev, Sergey P.
    Zakian, Suren M.
    STEM CELL RESEARCH, 2022, 59
  • [30] Generation of human induced pluripotent stem cell line (WMUi001-A) from a patient with aortic dissection
    Jin, Peifeng
    Wang, Sixian
    Jiang, Xu
    Shan, Xiaoqiong
    Jiang, Sheng
    Quan, Yingyi
    Zhang, Tianci
    Yang, Jiwen
    Zhang, Huang
    Ma, Jianshe
    Dong, Miaowu
    Fan, Junming
    Fan, Xiaofang
    Gong, Yongsheng
    Wang, Yongyu
    STEM CELL RESEARCH, 2020, 43
12345